Prediction of major adverse cardiovascular events in patients with COVID-19 who did not have prior cardiovascular pathology: a cohort study
Kazan medical journal · 05.06.2026 · 107 (4) · 519-527
DOI: 10.17816/kmj698675 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Kazan medical journal, online erschienen am 05.06.2026. Verfasst von Tatyana V. Kanaeva und 7 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: The novel coronavirus infection (COVID-19) is associated with a high risk of major adverse cardiovascular events (MACE) and venous thromboembolism in the posthospitalization period. AIM: To identify early predictors and develop a model for predicting longterm MACE in patients who have recovered from COVID-19, based on analysis of clinical, laboratory, and instrumental data. METHODS: A prospective study was conducted involving 112 patients without a history of cardiovascular disease who were hospitalized with a confirmed diagnosis of COVID-19 and grade 1–4 lung involvement on computed tomography. Upon admission, in addition to standard clinical, laboratory, and instrumental evaluation, levels of highsensitivity troponins T and I, Nterminal probrain natriuretic peptide, soluble suppression of tumorigenicity 2 (sST2), pentraxin3 (PTX3), and galectin3 (Gal3) were measured. During a twoyear followup, the development of MACE (acute cerebrovascular accident, acute myocardial infarction, pulmonary embolism, cardiovascular death) was assessed. Potential predictors of MACE were identified using logistic regression with stepwise variable selection (Forward method). RESULTS: During the followup period, MACE was recorded in 12.5% of patients. Differences in clinical, demographic, laboratory, and instrumental characteristics between patients with and without MACE were analyzed. Three independent predictors of MACE were identified: Gal3 5.1 ng/mL (p 0.001), sST2 48 ng/mL (p 0.001), and PTX3 9.6 ng/mL (p 0.001). Based on the multivariate model incorporating these three predictors, a calculator was developed to estimate the probability of MACE in patients without a history of cardiovascular disease who have recovered from COVID-19. CONCLUSION: The developed mathematical model has high predictive accuracy (80.0%) and can identify patients at high risk of MACE during posthospital followup.
Zitieren
APA
Kanaeva, T. V., Nemtseva, L. A., Popova, E. A., Ivashchenko, V. V., Abbasova, N. D., Zelentsova, A. Y., Bulaeva, Y. V., & Karoli, N. A. (2026). Prediction of major adverse cardiovascular events in patients with COVID-19 who did not have prior cardiovascular pathology: a cohort study. Kazan medical journal, 107(4), 519-527. https://doi.org/10.17816/kmj698675
Vancouver
Kanaeva TV, Nemtseva LA, Popova EA, Ivashchenko VV, Abbasova ND, Zelentsova AY, et al. Prediction of major adverse cardiovascular events in patients with COVID-19 who did not have prior cardiovascular pathology: a cohort study. Kazan medical journal. 2026;107(4):519-527. doi:10.17816/kmj698675
BibTeX
@article{Kanaeva2026,
author = {Kanaeva, Tatyana V. and Nemtseva, Lada A. and Popova, Ekaterina A. and Ivashchenko, Viktoriia V. and Abbasova, Nailya D. and Zelentsova, Angelina Y. and Bulaeva, Yulia V. and Karoli, Nina A.},
title = {Prediction of major adverse cardiovascular events in patients with COVID-19 who did not have prior cardiovascular pathology: a cohort study},
journal = {Kazan medical journal},
year = {2026},
volume = {107},
number = {4},
pages = {519--527},
doi = {10.17816/kmj698675}
}
EUVIMED